Clinical trial · Interventional
Checklist Tool in Engaging Patients in the Discharge Planning Process
Tool to Engage Patients in Discharge (TEPID)
NCT02942524CI-TRIAL-00046249TEPIDcompletedN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This clinical trial studies how well a checklist tool works in engaging patients in the discharge planning process. Engaging patients in the discharge process may increase participation in the discharge process and improve discharge outcomes, understanding of care after hospitalization, and decrease complications.
Conditions
Conditions (3)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Hospitalization | — | UNRESOLVED | — |
| Malignant Neoplasm | Malignant Neoplasm | ONTOLOGY_EXACT | 0.90 |
| Transitional Care Planning | — | UNRESOLVED | — |
Interventions
Interventions (3)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Communication Intervention | Other | — | UNRESOLVED |
| Questionnaire Administration | Other | — | UNRESOLVED |
| Survey Administration | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- EXPERIMENTAL
- label
- Supportive care (TEPID)
- description
- Patients complete the TEPID checklist of items during hospital stay.
- interventionNames
- Other: Communication Intervention
- Other: Questionnaire Administration
- Other: Survey Administration
Primary outcomes (5)
- measure
- Average score from the PADQ-E
- timeFrame
- Up to 12 months
- description
- A simple analysis of variance (ANOVA) model with floor as a fixed blocking factor treatment (TEPID or no TEPID) as a fixed factor. Unit appears in the model as a nested factor within treatment, and statistical tests will be adjusted for this nesting structure. The main test of interest in each model is the overall effect of treatment, which quantifies the effect of TEPID on the average score for the response. P-values below 0.05 for this effect will be considered statistically significant.
- measure
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 19 Years
Show eligibility criteria text
Inclusion Criteria: * Patients fluent in English, conscious, coherent, and alert or have an adult caregiver present that is fluent in English will be identified for the TEPID research project Exclusion Criteria: * Patients discharged to another inpatient facility (hospice, skilled nursing facility, long term acute care hospital \[LTACH\], or acute rehab) or patients discharged home with hospice will be excluded * Any patients that are transferred to another unit prior to discharge will be excluded
References
Publications (0)
Data not yet available
No reference posted for this study.